Literature DB >> 20598216

Problem-solving abilities and frontal lobe cortical thickness in healthy aging and mild cognitive impairment.

G Sánchez-Benavides1, B Gómez-Ansón, M Quintana, Y Vives, R M Manero, A Sainz, R Blesa, J L Molinuevo, J Peña-Casanova.   

Abstract

Mild cognitive impairment (MCI) is considered a transitional state between normal aging and Alzheimer disease. Most MCI subjects present disturbances in multiple neuropsychological domains, including executive function. This study aimed at exploring frontal lobe cortical thinning in MCI and healthy controls, and its relationship with problem-solving abilities. Twenty-three MCI patients and 30 elderly controls underwent MRI and neuropsychological assessment. Cortical thickness was measured by means of FreeSurfer. Problem-solving was assessed by means of the Tower of London (TOL) task. MCI showed a global thinning of the cortex. With regard to specific regions of interest, a thinning in the left frontal lobe and the bilateral posterior cingulate gyri was found. Partial correlations, after controlling for age, education, Mini-Mental Status Examination, and non-frontal mean thickness revealed negative significant correlations between frontal lobe thickness and executive outcomes in the control group. This counterintuitive relationship was not observed in the MCI group, suggesting that the frontal cortical atrophy observed in MCI entails a specific pathology-related relationship with high-level executive outcomes that is qualitatively different from that observed in healthy aging.

Entities:  

Mesh:

Year:  2010        PMID: 20598216     DOI: 10.1017/S135561771000069X

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  8 in total

1.  Selective association between cortical thickness and reference abilities in normal aging.

Authors:  Seonjoo Lee; Christian Habeck; Qolamreza Razlighi; Timothy Salthouse; Yaakov Stern
Journal:  Neuroimage       Date:  2016-06-25       Impact factor: 6.556

2.  The Tower of London (ToL) in Italy: standardization of the ToL test in an Italian population.

Authors:  Maddalena Boccia; Dario Marin; Giovanni D'Antuono; Paola Ciurli; Chiara Incoccia; Gabriella Antonucci; Cecilia Guariglia; Laura Piccardi
Journal:  Neurol Sci       Date:  2017-04-21       Impact factor: 3.307

3.  Are apathy and depression independently associated with longitudinal trajectories of cortical atrophy in mild cognitive impairment?

Authors:  Laura B Zahodne; Assawin Gongvatana; Ronald A Cohen; Brian R Ott; Geoffrey Tremont
Journal:  Am J Geriatr Psychiatry       Date:  2013-04-28       Impact factor: 4.105

4.  Gray and White Matter Contributions to Cognitive Frontostriatal Deficits in Non-Demented Parkinson's Disease.

Authors:  Catherine C Price; Jared Tanner; Peter T Nguyen; Nadine A Schwab; Sandra Mitchell; Elizabeth Slonena; Babette Brumback; Michael S Okun; Thomas H Mareci; Dawn Bowers
Journal:  PLoS One       Date:  2016-01-19       Impact factor: 3.240

Review 5.  Higher-Level Executive Functions in Healthy Elderly and Mild Cognitive Impairment: A Systematic Review.

Authors:  Ilaria Corbo; Maria Casagrande
Journal:  J Clin Med       Date:  2022-02-23       Impact factor: 4.241

6.  The thickness of posterior cortical areas is related to executive dysfunction in Alzheimer's disease.

Authors:  Luciano de Gois Vasconcelos; Andrea Parolin Jackowski; Maira Okada de Oliveira; Yoná Mayara Ribeiro Flor; Altay Alves Lino Souza; Orlando Francisco Amodeo Bueno; Sonia Maria Dozzi Brucki
Journal:  Clinics (Sao Paulo)       Date:  2014-01       Impact factor: 2.365

7.  Effects of tai chi on cognition and instrumental activities of daily living in community dwelling older people with mild cognitive impairment.

Authors:  Mei-Yi Siu; Diana T F Lee
Journal:  BMC Geriatr       Date:  2018-02-02       Impact factor: 3.921

8.  Planning ability impairments in probable Alzheimer's disease patients: Evidence from the Tower of London test.

Authors:  Corina Satler; Luiza Guimarães; Carlos Tomaz
Journal:  Dement Neuropsychol       Date:  2017 Apr-Jun
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.